Systematic Financial Management’s AbbVie ABBV Stock Holding History

Systematic Financial Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.34M	Hold	9,300	–	–	0.05%	203
2026 Q1	$2.02M	Hold	9,300	–	–	0.05%	195
2025 Q4	$2.12M	Hold	9,300	–	–	0.05%	191
2025 Q3	$2.15M	Hold	9,300	–	–	0.05%	181
2025 Q2	$1.73M	Hold	9,300	–	–	0.05%	190
2025 Q1	$1.95M	Hold	9,300	–	–	0.06%	178
2024 Q4	$1.65M	Hold	9,300	–	–	0.04%	192
2024 Q3	$1.84M	Hold	9,300	–	–	0.05%	187
2024 Q2	$1.6M	Hold	9,300	–	–	0.05%	191
2024 Q1	$1.69M	Hold	9,300	–	–	0.05%	189
2023 Q4	$1.44M	Hold	9,300	–	–	0.04%	185
2023 Q3	$1.39M	Hold	9,300	–	–	0.04%	181
2023 Q2	$1.25M	Hold	9,300	–	–	0.04%	181
2023 Q1	$1.48M	Hold	9,300	–	–	0.05%	173
2022 Q4	$1.5M	Hold	9,300	–	–	0.05%	176
2022 Q3	$1.25M	Hold	9,300	–	–	0.05%	167
2022 Q2	$1.42M	Hold	9,300	–	–	0.05%	166
2022 Q1	$1.51M	Hold	9,300	–	–	0.05%	165
2021 Q4	$1.26M	Hold	9,300	–	–	0.04%	158
2021 Q3	$1M	Hold	9,300	–	–	0.03%	158
2021 Q2	$1.05M	Hold	9,300	–	–	0.03%	160
2021 Q1	$1.01M	Hold	9,300	–	–	0.04%	157
2020 Q4	$996K	Hold	9,300	–	–	0.04%	158
2020 Q3	$815K	Hold	9,300	–	–	0.04%	160
2020 Q2	$913K	Hold	9,300	–	–	0.05%	157
2020 Q1	$709K	Hold	9,300	–	–	0.04%	159
2019 Q4	$823K	Sell	9,300 -310	-3%	-$25.7K	0.03%	172
2019 Q3	$728K	Sell	9,610 -16,637	-63%	-$1.14M	0.03%	171
2019 Q2	$1.91M	Sell	26,247 -3,228	-11%	-$254K	0.07%	194
2019 Q1	$2.38M	Sell	29,475 -3,533	-11%	-$289K	0.08%	230
2018 Q4	$3.04M	Buy	33,008 +5,158	+19%	+$454K	0.09%	231
2018 Q3	$2.63M	Sell	27,850 -405	-1%	-$38.4K	0.06%	271
2018 Q2	$2.62M	Buy	28,255 +18,955	+204%	+$1.85M	0.06%	257
2018 Q1	$880K	Hold	9,300	–	–	0.02%	559
2017 Q4	$899K	Hold	9,300	–	–	0.02%	553
2017 Q3	$826K	Hold	9,300	–	–	0.02%	557
2017 Q2	$674K	Hold	9,300	–	–	0.01%	598
2017 Q1	$606K	Hold	9,300	–	–	0.01%	599
2016 Q4	$582K	Hold	9,300	–	–	0.01%	588
2016 Q3	$587K	Hold	9,300	–	–	0.01%	558
2016 Q2	$575K	Sell	9,300 -209,640	-96%	-$12.8M	0.01%	549
2016 Q1	$12.5M	Sell	218,940 -7,077	-3%	-$394K	0.16%	158
2015 Q4	$13.4M	Sell	226,017 -41,303	-15%	-$2.38M	0.15%	141
2015 Q3	$14.5M	Sell	267,320 -23,784	-8%	-$1.55M	0.15%	138
2015 Q2	$19.6M	Sell	291,104 -48,326	-14%	-$3.15M	0.17%	137
2015 Q1	$19.9M	Buy	339,430 +79,737	+31%	+$4.82M	0.16%	149
2014 Q4	$17M	Sell	259,693 -190,805	-42%	-$12M	0.13%	164
2014 Q3	$26M	Sell	450,498 -5,316	-1%	-$295K	0.19%	126
2014 Q2	$25.7M	Sell	455,814 -62,995	-12%	-$3.3M	0.18%	135
2014 Q1	$26.7M	Buy	518,809 +68,896	+15%	+$3.48M	0.18%	136
2013 Q4	$23.8M	Buy	449,913 +189,618	+73%	+$9.32M	0.17%	144
2013 Q3	$11.6M	Buy	260,295 +256,895	+7,556%	+$11.4M	0.09%	220
2013 Q2	$140K	Buy	+3,400	New	+$149K	﹤0.01%	618

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Systematic Financial Management's ABBV Position: Q2 2026 in Review

Systematic Financial Management held its AbbVie (ABBV) position steady in Q2 2026 at 9,300 shares worth $2.34M. The position accounts for 0.05% of the portfolio, ranked #203.

Systematic Financial Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $26.7M in Q1 2014. 4,214 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Systematic Financial Management held 9,300 shares of AbbVie worth $2.34M as of Q2 2026.
Systematic Financial Management left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.05% of Systematic Financial Management's portfolio in Q2 2026, its #203 holding.
Systematic Financial Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
Systematic Financial Management's AbbVie position peaked at $26.7M in Q1 2014.
4,214 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Systematic Financial Management's 13F filing for Q2 2026, filed 14 Aug 2026.